Avanos Medical, Inc.
AVNS
$24.96
-$0.01-0.02%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.78% | 0.72% | 4.34% | 1.92% | 0.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.78% | 0.72% | 4.34% | 1.92% | 0.84% |
| Cost of Revenue | 13.26% | 16.30% | 18.45% | 8.94% | 8.98% |
| Gross Profit | 4.90% | -12.24% | -7.43% | -3.66% | -5.27% |
| SG&A Expenses | 1.45% | -4.39% | 3.90% | 3.21% | -8.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1,300.00% | -166.67% | 483.33% | -85.71% | -200.00% |
| Total Operating Expenses | 8.70% | 4.85% | 11.93% | 4.29% | -1.55% |
| Operating Income | 10.11% | -65.71% | -95.83% | -60.32% | 78.00% |
| Income Before Tax | -21.65% | 100.29% | -112.63% | -1,324.19% | 546.67% |
| Income Tax Expenses | -19.35% | 110.64% | -94.44% | -52.63% | 210.00% |
| Earnings from Continuing Operations | -22.73% | 99.67% | -123.73% | -1,886.05% | 1,220.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.73% | 99.67% | -132.56% | -4,366.67% | 833.33% |
| EBIT | 10.11% | -65.71% | -95.83% | -60.32% | 78.00% |
| EBITDA | 8.11% | -37.50% | -58.23% | -28.98% | 12.80% |
| EPS Basic | -23.39% | 99.68% | -132.30% | -4,331.38% | 834.36% |
| Normalized Basic EPS | 1.51% | -73.16% | -108.37% | -82.46% | 232.84% |
| EPS Diluted | -21.64% | 99.68% | -135.24% | -4,711.11% | 800.00% |
| Normalized Diluted EPS | 0.90% | -73.16% | -108.48% | -82.32% | 230.75% |
| Average Basic Shares Outstanding | 0.87% | 0.87% | 0.87% | 0.87% | -0.22% |
| Average Diluted Shares Outstanding | 1.50% | 0.87% | -0.43% | 0.00% | 0.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |